12 Transforming the Drug Development Landscape
Also Heading to the Clinic
Novel Stem Cell Trial Begins
A trial implanting dopamine cells created from engineered stem cells began in June. MJFF funded original studies to create dopamine cells— which are lost in Parkinson’ s— from this type of stem cell.
Troublesome Symptoms the Focus of New Trials
In 2021 MJFF allocated nearly $ 11 million in grants funding new approaches to ease some of the most troubling symptoms of Parkinson’ s, including constipation, depression, dyskinesia, gait freezing, speech issues, sleep problems and tremor.
$ 11M
to symptomatic therapies